Latest Health News from Duke Medicine News and Communications
Paraplegics Regain Some Feeling, Movement After Using Brain-Machine Interfaces
Aug. 11, 2016
Eight people who have spent years paralyzed from spinal cord injuries have regained partial sensation and muscle control in their lower limbs after training with brain-controlled robotics, according to a study published Aug. 11 in Scientific Reports.
Warfarin Use May Not Bring Long-Term Stability for Atrial Fibrillation
Aug. 9, 2016
Warfarin prescribed to prevent strokes in atrial fibrillation may not adequately control blood clotting over the long-term, even when patients have been historically stable on the drug, according to a study from the Duke Clinical Research Institute.
Compound Shows Promise as Next-Generation Prostate Cancer Therapy
Aug. 8, 2016
In the search for new ways to attack recurrent prostate cancer, researchers at Duke Health report that a novel compound appears to have a unique way of blocking testosterone from fueling the tumors in mice.
Duke Team Identifies New ‘Mega-Complex’ Involved in Cell Signaling
Aug. 4, 2016
Duke Health-led researchers have discovered new information about the signaling mechanism of cells that could one day help guide development of more specific drug therapies.
U.S. News & World Report Ranks Duke University Hospital Among Nation’s Best
Aug. 2, 2016
Duke University Hospital has been named the No. 16 medical center in the country by U.S. News & World Report, which released its annual hospital rankings today.
Coordinated Emergency Care Saves Lives, Lessens Damage During Heart Attack
Aug. 1, 2016
Patients suffering from deadly heart attacks can be spared more extensive heart damage when emergency responders and hospitals work together to standardize their treatment processes, according to a study published August 1 in Circulation, a journal of the American Heart Association (AHA).
Tracking How HIV Disrupts Immune System Informs Vaccine Development
July 29, 2016
One of the main mysteries confounding development of an HIV vaccine is why some people infected with the virus make the desired antibodies after several years, but a vaccine can’t seem to induce the same response. A research team led by scientists at the Duke Human Vaccine Institute has been unraveling that mystery, detailing new insights in a study published July 29 in the journal Science Immunology.
Study Identifies Potential New Avenue for Treating Pompe Disease
July 26, 2016
Researchers at Duke Health have identified a potential new avenue for treating Pompe disease, a rare condition caused by the build-up of glycogen, a storage form of sugar, in cardiac and skeletal muscle, the liver and other tissues, due to deficiency of a particular enzyme.
Physical Declines Begin Earlier Than Expected Among U.S. Adults
July 21, 2016
Physical declines begin sooner in life than typically detected, often when people are still in their 50s, according to a Duke Health study that focused on a large group of U.S. adults across a variety of age groups.
Duke to Participate in Early Clinical Trials for Emerging Neurological Therapies
July 21, 2016
Duke University could receive up to $19 million to lead early-stage clinical trials for new drugs to treat neurological conditions such as Alzheimer’s disease and neuropathy.